Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Current Research in Pharmacology and Drug Discovery|December 15, 2021
Progress towards a clinically-successful ATR inhibitor for cancer therapyFrancis M Barnieh, Paul M Loadman, Robert A FalconerAdvances in Clinical Chemistry|October 1, 2025
Aminopeptidase N (CD13): Bridging physiology, pathology and therapeutic potentialGabriel C Nwokolo, Robert A Falconer, Francis M BarniehBiochimica Et Biophysica Acta. Reviews on Cancer|October 25, 2021
Is tumour-expressed aminopeptidase N (APN/CD13) structurally and functionally unique?Francis M Barnieh, Paul M Loadman, Robert A FalconerOncogene|August 27, 2025
Decoding the adaptive survival mechanisms of breast cancer dormancyFrancis M Barnieh, Jamie Morton, Olaitan Olanrewaju, et al.Biochemical Pharmacology|May 22, 2022
Targeted delivery of a colchicine analogue provides synergy with ATR inhibition in cancer cellsFrancis M Barnieh, Goreti Ribeiro Morais, Herbie Garland, et al.The Journal of Organic Chemistry|October 20, 2022
Chemoselective Solution- and Solid-Phase Synthesis of Disulfide-Linked GlycopeptidesKatreen A F Banisalman, Athina Polykandritou, Francis M Barnieh, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 8, 2024
Hypoxia-Responsive Prodrug of ATR Inhibitor, AZD6738, Selectively Eradicates Treatment-Resistant Cancer CellsFrancis M Barnieh, Goreti Ribeiro Morais, Paul M Loadman, et al.Biology Open|October 17, 2023
Trailblazers in cancer research: the next generation - the British Association of Cancer Research early-career conferenceKyle K Greenland, Kathryn A F Pennel, Giorgia Cioccoloni, et al.Iscience|November 9, 2023
Cancer-specific glycosylation of CD13 impacts its detection and activity in preclinical cancer tissuesFrancis M Barnieh, Sebastian P Galuska, Paul M Loadman, et al.Frontiers in Cell and Developmental Biology|June 27, 2024
The DNA repair kinase ATM regulates CD13 expression and cell migrationLouise K Stevenson, Amy J Page, Matthew Dowson, et al.Pageof 2